President, IQVIA Asia Pacific
Executive Director, IQVIA Institute for Human Data Science
Head, Management Consulting, IQVIA China
Senior Vice President of Strategic Solutions, JAPAC
Senior Director, Clinical Operations, IQVIA China
As the pharmaceutical industry enters a new era shaped by accelerated innovation, shifting global dynamics, and rising demand for cross-border collaboration, strategic foresight has never been more critical.
In this evolving landscape, the relationship between global innovation hubs and emerging markets—particularly China—is becoming increasingly central. Chinese pharmaceutical assets and innovations are gaining significant momentum on the international stage, offering compelling opportunities for forward-thinking organizations.
In conjunction with the JP Morgan Annual Healthcare Conference, we are pleased to invite you to participate in the Pre-J.P. Morgan 8th IQVIA China Virtual Summit.
Key Takeaways:
Don't miss this opportunity to revolutionize your work and expand your global footprint. We look forward to your participation.
Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.
